Literature DB >> 2467241

Argon green laser treatment of peripapillary choroidal neovascular membranes.

A P Cialdini1, A E Jalkh, C L Trempe, F P Nasrallah, C L Schepens.   

Abstract

Of 27 eyes with peripapillary choroidal neovascular membranes (PPCNM), 17 (63%) had age-related macular degeneration and ten (37%) were idiopathic. PPCNM were treated in 25 eyes using the monochromatic green argon laser. Two eyes were untreatable. After an average follow-up of 37.7 months, successful closure of the choroidal new vessels was obtained in 23 eyes (92%), and visual acuity was stabilized or improved in 20 (80%). Seven eyes (28%) had recurrences; in four, the new vessels extended into the macula. Post-treatment, three eyes ultimately had dry macular scars, and one had an exudative macular scar. Of these four eyes, only the one with a dry macular scar showed visual improvement. No treated cases showed arcuate scotoma.

Entities:  

Mesh:

Year:  1989        PMID: 2467241

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  5 in total

1.  Surgical treatment of peripapillary choroidal neovascularisation.

Authors:  Susanne Binder
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

2.  Surgical treatment of peripapillary choroidal neovascularisation.

Authors:  S Aisenbrey; F Gelisken; P Szurman; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2007-02-14       Impact factor: 4.638

Review 3.  Treating peripapillary choroidal neovascular membranes: a review of the evidence.

Authors:  G Jutley; G Jutley; V Tah; D Lindfield; G Menon
Journal:  Eye (Lond)       Date:  2011-03-11       Impact factor: 3.775

4.  Juxtapapillary pigment epithelium detachment observed in asymptomatic participants using optical coherence tomography.

Authors:  Yanling Ouyang; Florian M Heussen; Pearse A Keane; Rajeev K R Pappuru; Srinivas R Sadda; Alexander C Walsh
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

5.  Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes.

Authors:  Sean D Adrean; Scott Grant; Siyang Chaili
Journal:  J Ophthalmol       Date:  2017-03-26       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.